Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants

QR Code

Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants

The SARS-CoV-2 virus, which causes COVID-19, has rapidly evolved, producing highly transmissible variants like Omicron. Non-structural protein 6 (NSP6) is essential for viral replication and immune evasion. This study analyzed the NSP6 protein of the Omicron variant, focusing on conserved motifs, mu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Joyhare Barbosa Souza, Samir Mansour Moraes Casseb
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	SynBio
Subjects:	SARS-CoV-2 Omicron variant NSP6 protein
Online Access:	https://www.mdpi.com/2674-0583/3/2/7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

Genomic Epidemiology of SARS-CoV-2 in Ukraine from May 2022 to March 2024 Reveals Omicron Variant Dynamics
by: Anna Iaruchyk, et al.
Published: (2025-07-01)

The Clinical Impact of the Omicron Variant on Octogenarian Hospitalized COVID-19 Patients: The Results from CoviCamp Cohort
by: Pierantonio Grimaldi, et al.
Published: (2025-06-01)

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)
by: V. I. Vechorko, et al.
Published: (2022-07-01)

Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape
by: Mohammed Alshahrani, et al.
Published: (2025-05-01)

SARS-CoV-2 sublineages recovered from southern Brazilian cases during Omicron wave in 2023, early introduction of JN.1
by: Mellanie Fontes-Dutra, et al.
Published: (2025-07-01)

A comparative study on the persistence and viability of SARS-CoV-2 wild-type and omicron variant on artificially contaminated surfaces: the role of fomites
by: Giovanna Fusco, et al.
Published: (2023-12-01)

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
by: Abundio Balgos, et al.
Published: (2024-12-01)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024-12-01)

The Omicron Variant of SARS-CoV-2 Virus: the Ability to Cause Disease in Persons with Immunity against COVID-19
by: T. E. Sizikova, et al.
Published: (2023-06-01)

SADS-CoV nsp5 Inhibits Interferon Production by Targeting Kinase IKKε
by: Gaoli She, et al.
Published: (2025-06-01)

The prognostic value of serum apolipoprotein A1 levels in elderly patients with de novo SARS-CoV-2 omicron infection
by: Cong Shi, et al.
Published: (2025-07-01)

Impact of Vaccination and Public Health Measures on the Severity of SARS-CoV-2 Omicron Infections in China: A Systematic Review and Meta-Regression Analysis
by: Can Wang, et al.
Published: (2025-07-01)

Mild SARS-CoV-2 Infection with the Omicron Variant Mimicking Metastatic Cancer on Whole-Body 18-F FDG PET/CT Imaging
by: Gunnhild Helmsdal, et al.
Published: (2025-06-01)

Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty
by: Liang En Wee, et al.
Published: (2025-05-01)

From Delta to Omicron—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
by: Maria Miklasińska-Majdanik, et al.
Published: (2025-07-01)

Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
by: Nadine Alvarez, et al.
Published: (2025-06-01)

Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
by: Anna Solastie, et al.
Published: (2023-12-01)

SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release
by: Hyejin Mun, et al.
Published: (2025-12-01)

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications
by: Alaa A. A. Aljabali, et al.
Published: (2025-07-01)

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
by: Jimena Pérez-Vargas, et al.
Published: (2023-12-01)

A Smart Single‐Loop‐Mediated Isothermal Amplification Facilitates Flexible SNP Probe Design for On‐Site Rapid Differentiation of SARS‐CoV‐2 Omicron Variants
by: Qijie Lin, et al.
Published: (2025-07-01)

RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests
by: Richard Creager, et al.
Published: (2021-01-01)

Development of a model by LASSO to predict hospital length of stay (LOS) in patients with the SARS-Cov-2 omicron variant
by: Jianxiang Zhang, et al.
Published: (2023-12-01)

SARS-CoV-2 Delta variant induces severe damage in the nasal cavity from the first day post-infection in the Syrian hamster model
by: Maxime Fusade-Boyer, et al.
Published: (2025-12-01)

Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1
by: Isabel Zydek, et al.
Published: (2025-08-01)

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1
by: Hongyu Wang, et al.
Published: (2023-12-01)

Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
by: Lucia Inchauste, et al.
Published: (2025-07-01)

Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids
by: Meaghan Flagg, et al.
Published: (2023-12-01)

Mutations in RNA‐dependent RNA polymerase could be major cause of high pandemic potential of SARS‐CoV‐2: An in‐silico study
by: Bhawna Sharma, et al.
Published: (2025-06-01)

Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya
by: Caitlin Greenland-Bews, et al.
Published: (2025-06-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Editorial: Emerging SARS-COV-2 variants: genomic variations, transmission, pathogenesis, clinical impact and interventions, volume III
by: Deepak Y. Patil, et al.
Published: (2025-07-01)

One-Year Monitoring of the Evolution of SARS-CoV-2 Omicron Subvariants Through Wastewater Analysis (Central Italy, August 2023–July 2024)
by: Alessandra Nappo, et al.
Published: (2025-05-01)

Droplet digital RT-PCR method for SARS-CoV-2 variants detection in clinical and wastewater samples
by: Feng Wang, et al.
Published: (2025-07-01)

SARS coronavirus-2 omicron variant transmission fractional order model with respiratory-specific and vaccination effects
by: Taohua Liu, et al.
Published: (2025-08-01)

Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study
by: Camila Amormino Corsini, et al.
Published: (2025-07-01)

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines
by: Mary Bausch-Jurken, et al.
Published: (2024-12-01)

Comparison of two polymerase chain reaction assays, DaAn Gene (DaAn Gene 2019-ncov) and Cepheid (Cepheid Xpert Xpress SARS-CoV-2) for Delta and Omicron variants of SARS-CoV-2 detection in Yaoundé, Cameroon
by: Martin Maidadi-Foudi, et al.
Published: (2025-07-01)